Table 3. Demographics, dietary diversity, infection and hemoglobinopathies among non-pregnant women of reproductive age, national, Ghana 2017.
| Characteristic | n a | % b | (95% CI) c |
|---|---|---|---|
| Residing in urban household | 474 | 49.8 | (37.3; 62.4) |
| Partly or fully literate | 591 | 74.3 | (69.8; 78.3) |
| Proportion with minimum dietary diversity | 541 | 47.2 | (42.3; 52.1) |
| Any inflammation d | 181 | 21.0 | (17.2; 25.4) |
| No inflammation | 806 | 79.0 | (74.6; 82.8) |
| Incubation (elevated CRP only) | 65 | 6.9 | (5.5; 8.7) |
| Early convalescence (elevated CRP and AGP) | 56 | 7.0 | (4.9; 10.0) |
| Late convalescence (elevated AGP only) | 60 | 7.1 | (5.4; 9.3) |
| Malaria parasitemia | 78 | 8.4 | (5.7; 12.2) |
| Sickle cell disease or trait e | 60 | 13.5 | (10.6; 17.1) |
| HbSS (disease) | 2 | 0.5 | (0.1; 1.9) |
| HbAS (trait) | 58 | 13.0 | (10.1; 16.7) |
| α-thalassemia (combined) e | 163 | 34.6 | (29.7; 39.7) |
| Homozygous | 19 | 4.4 | (2.7; 7.2) |
| Heterozygous | 144 | 30.1 | (25.4; 35.3) |
a Total n was 1053 for questionnaire-related variables, 947 for malaria, 987 for inflammation, 479 for sickle cell disorders, and 474 for α-thalassemia. The n’s are un-weighted numerators in each subgroup; the sum of subgroups may not equal the total because of missing data.
b Percentages weighted for unequal probability of selection.
c CI = confidence interval, calculated taking into account the complex sampling design.
d CRP = C-reactive protein, AGP = α1-acid-glycoprotein.
e Sickle cell disorders and α-thalassemia analyses were only conducted on ½ of randomly selected samples, thus the total number of samples analyzed was 479 for sickle cell disorders and 474 for thalassemia.